Patient monitoring systems manufacturer Opto Circuits (India) Ltd has informed Bombay Stock Exchange (BSE) that it bought US-based Unetixs Vascular Inc, a non-invasive vascular diagnostic systems manufacturer, for $9.7 million.
Unetixs Vascular designs and manufactures technically advanced US Food and Drug Administration (USFDA) approved non-invasive vascular diagnostic systems. The company is a specialist in the detection of peripheral arterial disease (PAD).
Opto Circuits will fund the acquisition through its internal accruals.
On Tuesday, Opto Circuits shares declined 2.8% to Rs256 on the BSE, while the Sensex closed 0.3% higher at 18,077 points.
Foreigners: After dumping shares earlier in the fortnight, foreign investors later bought into...
Mumbai-based Jyothy Laboratories Ltd said its first quarter net profit rose to Rs25.7 crore against the net profit of Rs21.98 crore recorded in June quarter a year ago.
During the quarter to end-June, its total revenues increased to Rs153.4 crore from Rs119.7 crore, same period a year ago. The company's net sales during the June 2010 quarter rose to Rs151.3 crore from Rs119.5 crore during the same quarter last year, it said in a regulatory filing.
On Tuesday, Jyothy Laboratories shares ended 3% higher at Rs282 on the Bombay Stock Exchange, while the Sensex closed 0.3% up at 18,077 points.